PLX

Protalix Biother

2.380

+0.030+1.28%

After Hours: 2.377 -0.003 -0.12%18:22 08/20 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.320/2.350

TODAY RANGE2.310-2.390

VOL384.48K

MARKET CAP191.76M

52 WEEK RANGE1.465-3.190

AVG VOL (3M)682.44K

% TURNOVER0.48%

TURNOVER--

P/E (TTM)10.52

% RANGE3.40%

EPS(TTM)0.2262

P/E(FORWARD)12.53

P/B2.686

BVPS0.8862

DIVIDEND--

P/S3.629

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP184.32M

SHARES OUTSTANDING80.57M

NEXT EARNINGS11/11-11/16

FREE FLOAT77.45M

LOT SIZE1

EX-DATE12/20/2019

News

Press Releases

Financial Reports

Profile

Seeking Alpha·08/12 10:57
Protalix BioTherapeutics GAAP EPS of $0.05 beats by $0.06, revenue of $19.8M beats by $6.87M
Seeking Alpha·08/11 22:00
Here are the major earnings before the open Wednesday
Seeking Alpha·08/11 15:10
Protalix BioTherapeutics Q2 Earnings Preview
PR Newswire·08/05 10:50
Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026
TipRanks·06/25 20:48
Protalix Shareholders Approve Directors, Compensation and Incentive Plan
TipRanks·05/26 10:35
Ram Selvaraju Reiterates Buy on Protalix, Maintains $12 Price Target on Elfabrio Momentum and Pipeline Upside
TipRanks·05/21 11:33
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
TipRanks·05/14 00:15
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
Seeking Alpha·05/13 15:52
Protalix reaffirms $78M-$83M 2026 revenue outlook following $25M Elfabrio milestone
Seeking Alpha·05/13 10:53
Protalix BioTherapeutics give Q1 results
PR Newswire·05/13 10:50
Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results
Seeking Alpha·05/12 22:00
Here are the major earnings before the open Wednesday
Seeking Alpha·05/12 18:07
Protalix BioTherapeutics Q1 Earnings Preview
Seeking Alpha·04/15 18:47
Protalix: Elfabrio Struggles Against Oral Competition
TipRanks·04/02 00:28
Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-0.24%

866.93

Biogen Inc

BIIB

+1.63%

212.55

Amgen Inc

AMGN

-0.63%

415.21

SHPG

CELG-RT

Lilly Eli & Co

LLY

+0.25%

CELG

Therapeuticsmd Inc

TXMD

-0.48%

2.070

Johnson & Johnson

JNJ

+0.78%

262.37

Abbvie Inc

ABBV

-1.49%

262.01

Zoetis Inc

ZTS

-2.70%

73.79

Gilead Sciences Inc

GILD

+0.16%

138.36

Novo-Nordisk A/S

NVO

-1.78%

45.89

Bristol-Myers Squibb Co

BMY

-1.27%

63.83

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+0.30%

26.87

Sanofi FR

SNY

-0.14%

43.72

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.55%

150.88

Dr Reddys Labs

RDY

-1.18%

12.13

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.